New angel investment network seeks applicants
A new community-supported angel network has sprung up in Atlanta with the goal of connecting early-stage biomedical, medtech and healthcare-related companies with angel investors interested in advancing technologies.
The Bio/Med Investor Network was created in late 2014 and is supported by Georgia Bio, the Georgia Research Alliance and Georgia's reserach universities, according to information on the network's website. It is comprised of high net-worth accredited investors who have joined together to evaluate and make individual investments in early-stage biosciences and certain other healthcare companies.
The network currently is seeking applications from early-stage companies and says its "typical investment stage target is from $200,000 to $2,000,000, but companies outside of these stages of fundraising will also be considered. Our highly qualified screening committee will select a limited number of applicants for an opportunity to present to our members at one of our quarterly dinners."
More information is available on the network's website.
Editor
Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.